Glaucoma and retinal disorders
Glaucoma and retinal disorders is a research topic within Ophthalmology. Science Explorer counts 73k research works in it since 1950. 15.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the global prevalence, treatment, and risk factors associated with glaucoma. It covers topics such as intraocular pressure, optic nerve damage, retinal ganglion cell loss, neurodegeneration, and the use of optical coherence tomography for diagnosis and monitoring. The papers also discuss the impact of ocular hypertension, risk factors for visual field progression, and primary open-angle glaucoma.
- Glaucoma
- Intraocular Pressure
- Optic Nerve
- Retinal Ganglion Cells
- Ocular Hypertension
- Optical Coherence Tomography
- Neurodegeneration
- Risk Factors
- Visual Field Progression
- Primary Open-Angle Glaucoma
- Research works
- 73k fractional, since 1950
- In the world top 10%
- 11k per year above
- Top-10% rate
- 15.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +16% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Glaucoma and retinal disorders research?
By volume, the United States and China publish the most (2k and 1.7k works in 2022–2025).
By volume, 2022–2025
- 1 United States 2k works
- 2 China 1.7k works
- 3 India 1.1k works
- 4 Japan 493 works
- 5 Germany 455 works
- 6 United Kingdom 438 works
- 7 South Korea 387 works
- 8 Türkiye 341 works
- 9 Spain 339 works
- 10 Russia 325 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Glaucoma and retinal disorders research?
By volume in 2022–2025, All India Institute of Medical Sciences publishes the most Glaucoma and retinal disorders research, followed by Sun Yat-sen University and Aravind Eye Hospital.
By volume, 2022–2025
- 1 All India Institute of Medical SciencesIndia 80 works
- 2 Sun Yat-sen UniversityChina 80 works
- 3 Aravind Eye HospitalIndia 73 works
- 4 L V Prasad Eye InstituteIndia 68 works
- 5 Creative CommonsUnited States 55 works
- 6 Wenzhou Medical UniversityChina 42 works
- 7 Intersectoral Research and Technology Complex Eye MicrosurgeryRussia 41 works
- 8 Beijing Tongren HospitalChina 41 works
- 9 University of MiamiUnited States 41 works
- 10 Capital Medical UniversityChina 41 works
Who are the leading researchers in Glaucoma and retinal disorders?
The most-cited researchers publishing on Glaucoma and retinal disorders include Jost B. Jonas, Songhomitra Panda‐Jonas and Konrad Pesudovs.
- 1 Jost B. Jonas Germany 7.7k citations
- 2 Songhomitra Panda‐Jonas Germany 4.6k citations
- 3 Konrad Pesudovs Australia 4.4k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Glaucoma and retinal disorders research done?
The largest centres of Glaucoma and retinal disorders research in 2022–2025 are Beijing (China), Moscow (Russia), Seoul (South Korea) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in East Melbourne, Madurai and Mountain View.
Largest cities, 2022–2025
Where it is the local speciality
- East MelbourneAU · 20.8 works70×
- MaduraiIN · 74.1 works26×
- Mountain ViewUS · 55.2 works9.3×
- WenzhouCN · 82.0 works8.9×
Location quotient: how much more of its research is in Glaucoma and retinal disorders than the world average.
Where is the best place to study Glaucoma and retinal disorders?
Among universities, judged by research, Duke-NUS Medical School, All India Institute of Medical Sciences and Medical University of Białystok score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Duke-NUS Medical SchoolSingapore | 72.2 | 31.5% | 19.2× | 15 | +194.7% |
| 2 | All India Institute of Medical SciencesIndia | 60.0 | 10.1% | 12.6× | 80 | +72.6% |
| 3 | Medical University of BiałystokPoland | 57.3 | 32.5% | 12.1× | 11 | +39.2% |
| 4 | Wenzhou Medical UniversityChina | 57.2 | 18.8% | 11.7× | 42 | +12.3% |
| 5 | Capital Medical UniversityChina | 52.4 | 21.2% | 6.8× | 41 | +43.7% |
| 6 | University of MiamiUnited States | 52.1 | 19.6% | 8.1× | 41 | -16.1% |
| 7 | University of Alabama at BirminghamUnited States | 52.1 | 41.7% | 3.9× | 20 | +29.8% |
| 8 | Sun Yat-sen UniversityChina | 50.9 | 21.7% | 4.8× | 80 | -2.4% |
| 9 | Shimane UniversityJapan | 50.9 | 17.1% | 21.9× | 17 | +44.2% |
| 10 | Medical University of ViennaAustria | 50.4 | 31.1% | 5.0× | 16 | +57.5% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Glaucoma and retinal disorders research growing?
Output in 2018–2022 was 16% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Glaucoma and retinal disorders.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.